Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis.
about
Troponin elevation in conditions other than acute coronary syndromesHigh-sensitivity troponin assays: evidence, indications, and reasonable useCardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis.Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometryChief Complaint at Admission Relates to Troponin Level and Mortality in Patients With Non-ACS Troponin Elevation.Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study.Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies.Independent value of cardiac troponin T and left ventricular global longitudinal strain in predicting all-cause mortality among stable hemodialysis patients with preserved left ventricular ejection fractionBiomarkers in predicting mortality and treatment in hemodialysis patientsComparison of plasma microRNA-1 and cardiac troponin T in early diagnosis of patients with acute myocardial infarction.Associations of tissue Doppler imaging with NT-proBNP and hs-TnT: a pilot study in end-stage renal diseaseThe non-cardiac use and significance of cardiac troponins.Sensitive troponins--which suits better for hemodialysis patients? Associated factors and prediction of mortality.Elevated troponin I levels but not low grade chronic inflammation is associated with cardiac-specific mortality in stable hemodialysis patients.Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation.Cardiac markers in the early diagnosis and management of patients with acute coronary syndromeA more appropriate cardiac troponin T level that can predict outcomes in end-stage renal disease patients with acute coronary syndrome.Improving prognosis estimation in patients with heart failure and the cardiorenal syndromeB-type natriuretic peptide and prognosis of end-stage renal disease: a meta-analysis.Cardiac biomarkers and health-related quality of life in new hemodialysis patients without symptomatic cardiac disease.Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal DiseaseSerum high-sensitivity cardiac troponin T is a significant biomarker of left-ventricular diastolic dysfunction in subjects with non-diabetic chronic kidney disease.Cardiac biomarkers in the intensive care unitMyocardial Stunning with Hemodialysis: Clinical Challenges of the Cardiorenal Patient.Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.Kidney Function Alters the Relationship between Postoperative Troponin T Level and Death.NT-proBNP: is it a more significant risk factor for mortality than troponin T in incident hemodialysis patients?Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population: A meta-analysis.Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial.Aprotinin in cardiac surgery.Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.Clinical significance of troponin elevations in acute decompensated diabetes without clinical acute coronary syndromeComparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction.Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients.Need for quality improvement in renal systematic reviews.Variation in and prognostic importance of troponin T measured using a high-sensitivity assay in clinically stable haemodialysis patientsWhich Biomarker is the Best for Predicting Mortality in Incident Peritoneal Dialysis Patients: NT-ProBNP, Cardiac TnT, or hsCRP?: A Prospective Observational StudyHemodialysis-induced cardiac injury: determinants and associated outcomes.Is cardiac biomarkers and left ventricular function affected by chronic kidney disease?Diastolic function is a strong predictor of mortality in patients with chronic kidney disease.
P2860
Q24630238-0FB6A447-5A3A-4B24-A50D-C3711582B2B7Q27007551-01EA6BE9-C96D-4ED1-A3FD-DFB4BE374B35Q27687888-2433AC9C-76D6-422F-9B41-3E2E079FE4F5Q28395328-D8984CBB-8CFA-498A-AA49-2D1690EB35F6Q33165629-CBF45F42-1CE6-494B-874E-C3205E974116Q33506787-2EEF7CD2-95E1-4B4F-A583-CF44685BA0D1Q33578171-66D8AF4A-17B7-4E92-ACCD-AAD5339AB879Q33660370-B033AC3D-1934-4F4A-A861-72F585C6C665Q34062442-32810412-B4B5-4C85-82DB-3FB2ADB3F622Q34179703-DE53398B-C926-4329-AAD5-8E18DFF7D063Q34214652-B6F8AC5A-7CDA-462D-BB39-65A76D2E768BQ34425048-700B8E44-DFC6-4988-A063-6A16EC5D2C03Q34451008-10B19738-B941-47CA-BB97-5BFE7B19AAC2Q34481564-FFECB3F5-B7F1-48CE-94D7-7005B0527543Q34610511-41A5C783-1E59-4F3E-9D55-1C5CDA8BF10FQ34782895-005BD89F-E985-47A1-8504-B871DA3470BDQ35014777-D09D4068-27C4-48FF-AE68-72E8404C9C10Q35020305-B6395A62-43E5-480F-8485-BDA35DE82E23Q35043782-5FFF3F6D-B86A-4802-9336-6B85DF3DADB5Q35674143-DCC03D73-2645-4D50-829B-CE8ABCDB828AQ35735050-B34E8910-7D04-47AF-B2C6-33DC71AA35FCQ35791735-08A5E21C-CCDD-4FA1-8D18-4C31B3FDF9ABQ35856435-3568E217-785C-4E8A-BA43-09F0A849100BQ36036002-31145269-9FA2-40CE-B5F3-B4212164F9C6Q36095018-70107209-2486-4F69-8EE7-7982E0222307Q36104791-7A4F1D66-BF4A-44E1-9AF6-DB79BA8E4619Q36152500-0166305D-4380-49C2-834A-D5F74A7529DDQ36235438-BB9D453C-C139-4D6C-A3A9-4F245CA08E45Q36383953-33570DF1-4C8D-4A7E-8DEA-1E804A6CC68EQ36410418-0E2A6E3C-DAD8-4ACE-96D3-9C1E74AC73F1Q36476324-09E1FBE9-5E1D-4E4A-BEEB-C45E29068268Q36548147-B3EE77AF-4372-42B7-BC52-9987B13275EAQ36555021-85A1E00C-E7C9-4FF8-B4D2-9444E9292D06Q36690931-581144AC-EA1A-4481-A841-F6B8E5BA5940Q36736617-8BD720C9-C213-439A-9C4E-AB6AD9223C96Q36982063-F144E2DD-7C6A-4FF4-8E88-95AB9593DB77Q37026079-11BD329F-DFC5-4AC9-92B6-ACF774F61D51Q37176822-D791B9DB-D94E-4FCC-BC78-0A1F763F7609Q37388147-89791A5C-70E7-4D2F-8F52-5E0FB9ACB8BAQ37425286-F7F2473E-4E4C-485B-8EF2-A2CF03418F6F
P2860
Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Prognostic value of troponin T ...... enal disease: a meta-analysis.
@ast
Prognostic value of troponin T ...... enal disease: a meta-analysis.
@en
Prognostic value of troponin T ...... enal disease: a meta-analysis.
@nl
type
label
Prognostic value of troponin T ...... enal disease: a meta-analysis.
@ast
Prognostic value of troponin T ...... enal disease: a meta-analysis.
@en
Prognostic value of troponin T ...... enal disease: a meta-analysis.
@nl
prefLabel
Prognostic value of troponin T ...... enal disease: a meta-analysis.
@ast
Prognostic value of troponin T ...... enal disease: a meta-analysis.
@en
Prognostic value of troponin T ...... enal disease: a meta-analysis.
@nl
P2093
P1433
P1476
Prognostic value of troponin T ...... enal disease: a meta-analysis.
@en
P2093
Adeera Levin
Brenda R Hemmelgarn
Nadia A Khan
P304
P356
10.1161/CIRCULATIONAHA.105.560128
P407
P577
2005-11-01T00:00:00Z